Maunjaro Kwikpen 15 mg

Mounjaro (Tirzepatide) is an injectable medicine used to help adults manage their weight. It works by acting on hormones that control appetite, helping to reduce hunger and make you feel fuller.

Mounjaro (Tirzepatide) is a once-weekly injection that helps regulate blood sugar and reduce appetite. It mimics two natural hormones—GLP-1 and GIP—to slow digestion, improve insulin release, and make you feel fuller for longer. Mounjaro was initially approved for type 2 diabetes but is also effective for weight loss. It has been approved for obesity treatment.

Mounjaro is used for type 2 diabetes to help lower blood sugar levels. Mounjaro has also been shown to help with weight loss and maintain the lost weight in clinical trials when combined with diet and exercise. It is a once-weekly injection that can be self-administered and should be used alongside dietary changes and exercise.

Mounjaro works by activating two gut hormone receptors, GIP and GLP-1, to manage blood sugar. This stimulates insulin release when glucose is high, reduces liver glucagon production, slows stomach emptying to control post-meal sugar spikes, and increases fullness to reduce appetite and food intake.

Side effects:

The most common side effects of Mounjaro are:

nausea

diarrhea

decreased appetite

vomiting

constipation

indigestion

stomach (abdominal) pain.

These side effects are usually mild and only last a short time.

Storage Instructions:

Store unused pens in the refrigerator (36°F–46°F / 2°C–8°C)

Can remain at room temperature (≤86°F / 30°C) for up to 21 days

Do not freeze or expose to direct sunlight

Keep out of reach of children